1-215741484-T-C

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_206933.4(USH2A):​c.11602A>G​(p.Met3868Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.216 in 1,613,586 control chromosomes in the GnomAD database, including 38,998 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M3868L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.21 ( 3492 hom., cov: 31)
Exomes 𝑓: 0.22 ( 35506 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -2.26
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a domain Fibronectin type-III 24 (size 97) in uniprot entity USH2A_HUMAN there are 25 pathogenic changes around while only 7 benign (78%) in NM_206933.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0016642809).
BP6
Variant 1-215741484-T-C is Benign according to our data. Variant chr1-215741484-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 48378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-215741484-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.229 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.11602A>G p.Met3868Val missense_variant Exon 60 of 72 ENST00000307340.8 NP_996816.3 O75445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.11602A>G p.Met3868Val missense_variant Exon 60 of 72 1 NM_206933.4 ENSP00000305941.3 O75445-1
USH2AENST00000674083.1 linkc.11602A>G p.Met3868Val missense_variant Exon 60 of 73 ENSP00000501296.1 O75445-3

Frequencies

GnomAD3 genomes
AF:
0.210
AC:
31814
AN:
151834
Hom.:
3494
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.230
Gnomad AMR
AF:
0.218
Gnomad ASJ
AF:
0.197
Gnomad EAS
AF:
0.107
Gnomad SAS
AF:
0.0813
Gnomad FIN
AF:
0.233
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.232
Gnomad OTH
AF:
0.235
GnomAD3 exomes
AF:
0.196
AC:
49194
AN:
251298
Hom.:
5194
AF XY:
0.194
AC XY:
26354
AN XY:
135822
show subpopulations
Gnomad AFR exome
AF:
0.190
Gnomad AMR exome
AF:
0.199
Gnomad ASJ exome
AF:
0.200
Gnomad EAS exome
AF:
0.0936
Gnomad SAS exome
AF:
0.0984
Gnomad FIN exome
AF:
0.237
Gnomad NFE exome
AF:
0.229
Gnomad OTH exome
AF:
0.214
GnomAD4 exome
AF:
0.217
AC:
317029
AN:
1461636
Hom.:
35506
Cov.:
35
AF XY:
0.213
AC XY:
155180
AN XY:
727104
show subpopulations
Gnomad4 AFR exome
AF:
0.192
Gnomad4 AMR exome
AF:
0.203
Gnomad4 ASJ exome
AF:
0.201
Gnomad4 EAS exome
AF:
0.136
Gnomad4 SAS exome
AF:
0.100
Gnomad4 FIN exome
AF:
0.241
Gnomad4 NFE exome
AF:
0.230
Gnomad4 OTH exome
AF:
0.209
GnomAD4 genome
AF:
0.209
AC:
31826
AN:
151950
Hom.:
3492
Cov.:
31
AF XY:
0.207
AC XY:
15354
AN XY:
74290
show subpopulations
Gnomad4 AFR
AF:
0.190
Gnomad4 AMR
AF:
0.218
Gnomad4 ASJ
AF:
0.197
Gnomad4 EAS
AF:
0.107
Gnomad4 SAS
AF:
0.0817
Gnomad4 FIN
AF:
0.233
Gnomad4 NFE
AF:
0.232
Gnomad4 OTH
AF:
0.232
Alfa
AF:
0.212
Hom.:
4815
Bravo
AF:
0.207
TwinsUK
AF:
0.231
AC:
855
ALSPAC
AF:
0.236
AC:
911
ESP6500AA
AF:
0.190
AC:
835
ESP6500EA
AF:
0.233
AC:
2006
ExAC
AF:
0.196
AC:
23802
Asia WGS
AF:
0.108
AC:
376
AN:
3478
EpiCase
AF:
0.230
EpiControl
AF:
0.230

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Apr 16, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 26, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 19, 2013
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 20, 2008
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Usher syndrome type 2A Benign:2
Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Benign:1
Oct 25, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.84
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.0020
DANN
Benign
0.52
DEOGEN2
Benign
0.037
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.33
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.20
N
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.33
N
REVEL
Benign
0.017
Sift
Benign
1.0
T
Sift4G
Benign
0.71
T
Polyphen
0.0
B
Vest4
0.028
MPC
0.030
ClinPred
0.014
T
GERP RS
-9.7
Varity_R
0.050
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35309576; hg19: chr1-215914826; COSMIC: COSV56342893; API